Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OSBPL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MED19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PLK1S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAB39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
URB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM187A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FERMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6883 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC23A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ISCA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928615 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TULP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP13A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGCR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on